Non-pertussis Components Of Combination Vaccines: Problems With Potency Testing.
D. Sesardic, C. R. Dawes, K. Mclellan, Z. Durrani, S. E. Yost, M. Corbel
Published 1999 · Medicine, Biology
Download PDFAnalyze on Scholarcy
Vaccines comprising combinations of diphtheria, tetanus and pertussis (DTP) with Haemophilus influenzae type b polysaccharide-protein conjugate (Hib), inactivated poliomyelitis virus (IPV) and hepatitis B virus (HBV) are already available, and new combinations using acellular pertussis components in a triple vaccine (DTaP) are under development. Evidence to date has shown that control of the efficacy, safety and stability of combination vaccines cannot be based on information already available on the individual components or existing licensed formulations. Several examples of immunological interference between components of a combination vaccine have been observed both in clinical trials and in laboratory tests. Examples of these for D, T and Hib components in DTP and DTaP combinations have been investigated.
This paper references
Comparative study of Lederle/Takeda acellular and Lederle whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants in Germany.
U. Heininger (1994)
Comparison of 13 acellular pertussis vaccines: overview and serologic response.
K. M. Edwards (1995)
Poor response to hib (PRP-T) vaccine when combined with an acellular pertussis/diphtheria/tetanus vaccine for primary immunization of infants.
F. Bell (1999)
Comparative study of a whole-cell pertussis vaccine and a recombinant acellular pertussis vaccine. The Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
A. Podda (1994)
A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
D. Greco (1996)
Immunization against diphtheria with special emphasis on immunization of adults.
A. Galazka (1996)
Responses to primary and a booster dose of acellular, component, and whole-cell pertussis vaccines initiated at 2 months of age.
L. Huang (1996)
A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.
L. Gustafsson (1996)
Control testing of combined vaccines: a consideration of potential problems and approaches.
M. Corbel (1994)
Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell pertussis vaccines: value of laboratory tests as predictors of clinical performance.
E. Miller (1997)
Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine.
R. Gupta (1999)
This paper is referenced by
Recombinant Hepatitis B Vaccines‐Characterization of the Viral Disease and Vaccine Production in the Methylotrophic Yeast, Hansenula polymorpha
S. Schaefer (2000)
Combined administration in a single injection of a feline multivalent modified live vaccine against FHV, FCV, and FPLV together with a recombinant FeLV vaccine is both safe and efficacious for all four major feline viral pathogens
T. Kanellos (2008)
Animal Refinement and Reduction: Alternative Approaches for Potency Testing of Diphtheria and Tetanus Vaccines
P. Stickings (2011)
Innovative vaccine production technologies: The evolution and value of vaccine production technologies
Kyungdong Bae (2009)
Potency tests of combination vaccines.
R. Taffs (2001)
Successful induction of protective antibody responses against Haemophilus influenzae type b and diphtheria after transcutaneous immunization with the glycoconjugate polyribosyl ribitol phosphate-cross-reacting material 197 vaccine.
F. Mawas (2004)
Effects of simultaneous immunization of Haemophilus influenzae type b conjugate vaccine and diphtheria-tetanus-acellular pertussis vaccine on anti-tetanus potencies in mice, guinea pigs, and rats.
Tadashi Fukuda (2013)
Whole-cell pertussis vaccine potency assays: the Kendrick test and alternative assays
Dorothy K-L Xing (2014)
Calibration of replacement international standard and European Pharmacopoeia Biological Reference Preparation for Diphtheria Toxoid, Adsorbed.
D. Sesardic (2001)
Influence of the Co-Administration of Heptavalent Conjugate Vaccine PCV7-TT on the Immunological Response Elicited by VA-MENGOC-BC® and Heberpenta®-L in Rabbits
Carlos Espinosa-Viñals (2017)
Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines-part 1.
R. Winsnes (2004)
Childhood and malaria vaccines combined in biodegradable microspheres produce immunity with synergistic interactions.
M. Peyre (2004)
Manufacturing issues related to combining different antigens: an industry perspective.
J. Hoof (2001)
Applications and optimization of immunization procedures.
M. Schunk (2005)
A recombinant chimera comprising the R1 and R2 repeat regions of M. hyopneumoniae P97 and the N-terminal region of A. pleuropneumoniae ApxIII elicits immune responses
S. Lee (2014)
An experimental divalent vaccine based on biodegradable microspheres induces protective immunity against tetanus and diphtheria.
M. Peyre (2003)
Development and use of a novel in vitro assay for testing of diphtheria toxoid in combination vaccines.
Laura Coombes (2009)